One Stop Shop for All Your Market Research Reports

Anticoagulants Market, Global Outlook and Forecast 2023-2029

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment. This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants. This report contains market size and forecasts of Anticoagulants in global, including the following market information: Global Anticoagulants Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global Anticoagulants market was valued at US$ 26700 million in 2022 and is projected to reach US$ 36330 million by 2029, at a CAGR of 4.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares. North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulants companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Anticoagulants Market, by Type, 2018-2023, 2024-2029 ($ millions) Global Anticoagulants Market Segment Percentages, by Type, 2022 (%) Platelet Aggregation Inhibitors (PAI) Low-Molecular-Weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Direct Factor Xa Inhibitors (DFXa) Vitamin K antagonists (VKA) Others Global Anticoagulants Market, by Application, 2018-2023, 2024-2029 ($ millions) Global Anticoagulants Market Segment Percentages, by Application, 2022 (%) VTE ACS/MI AF Others Global Anticoagulants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global Anticoagulants Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Anticoagulants revenues in global market, 2018-2023 (estimated), ($ millions) Key companies Anticoagulants revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Sanofi Bristol-Myers Squibb Bayer Johnson & Johnson. Genentech (Roche) Boehringer Ingelheim Lilly Daiichi Sankyo Otsuka AstraZeneca Pfizer Aspen The Medicines Company Outline of Major Chapters: Chapter 1: Introduces the definition of Anticoagulants, market overview. Chapter 2: Global Anticoagulants market size in revenue. Chapter 3: Detailed analysis of Anticoagulants company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Anticoagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Anticoagulants Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Anticoagulants Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 1403010
Category
  • Pharmaceuticals and Healthcare
Published on 16-Jan
Number of Pages 69
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(50)